Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19

INTRODUCTION: Olfactory dysfunction (OD) is a well know symptom of coronavirus disease 2019 (COVID-19), accounting for 48 to 85% of patients. In 1 to 10% of cases, patients develop a chronic olfactory dysfunction (COD), lasting more than 6 months. Recently, platelet-rich plasma (PRP) was used in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffens, Younès, Le Bon, Serge-Daniel, Lechien, Jerome, Prunier, Léa, Rodriguez, Alexandra, Saussez, Sven, Horoi, Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336533/
https://www.ncbi.nlm.nih.gov/pubmed/35904632
http://dx.doi.org/10.1007/s00405-022-07560-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336533/
https://www.ncbi.nlm.nih.gov/pubmed/35904632
http://dx.doi.org/10.1007/s00405-022-07560-y

Ejemplares similares